DE
56
3
CMS
67
2
NAVI
40
4
JWN
53
-4
CSX
62
5
HCA
70
-3
KR
52
3
ZBH
53
-3
PPL
67
3
UA
59
2
DVN
25
4
PRGO
39
2
EIX
74
2
EMC
68
-3
UAL
67
-2
GM
55
3
NTRS
40
-4
PCAR
48
2
MAR
65
2
CI
65
3
DE
56
3
CMS
67
2
NAVI
40
4
JWN
53
-4
CSX
62
5
HCA
70
-3
KR
52
3
ZBH
53
-3
PPL
67
3
UA
59
2
DVN
25
4
PRGO
39
2
EIX
74
2
EMC
68
-3
UAL
67
-2
GM
55
3
NTRS
40
-4
PCAR
48
2
MAR
65
2
CI
65
3
Financhill
Back

The Joint Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
29

JYNT
The Joint

Last Price:
11.62
Seasonality Move:
-0.76%
Sell
36

SRPT
Sarepta Therapeutics

Last Price:
124.65
Seasonality Move:
-1.39%
Sell
29
The Joint (JYNT) is a Sell

Is The Joint a Buy, Sell or Hold?

  • The current The Joint [JYNT] share price is $11.59. The Score for JYNT is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
  • JYNT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
36
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $124.53. The Score for SRPT is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

JYNT Stock Price Chart

What is The Joint's stock price today?

  • The The Joint share price today is $11.59
    The current trend is relatively stagnant and JYNT is experiencing selling pressure, which indicates risk of future bearish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $124.53
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing slight selling pressure.

JYNT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.1 Sell
Relative Strength Index (14 RSI): 50.38 Buy
Chaikin Money Flow: -19879 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (11.06 - 11.66) Buy
Bollinger Bands (100): (11.55 - 15.35) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.18 Sell
Relative Strength Index (14 RSI): 35.54 Sell
Chaikin Money Flow: -49995 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (124.27 - 135.95) Sell
Bollinger Bands (100): (123.89 - 147.49) Sell

JYNT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 11.44 Buy
20-day SMA: 11.38 Buy
50-day SMA: 12 Sell
200-day SMA: 12.15 Sell
8-day EMA: 11.45 Buy
20-day EMA: 11.47 Buy
50-day EMA: 11.96 Sell
200-day EMA: 12.46 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 125.45 Sell
20-day SMA: 127.75 Sell
50-day SMA: 135.2 Sell
200-day SMA: 127.53 Sell
8-day EMA: 125.39 Sell
20-day EMA: 128.04 Sell
50-day EMA: 132.59 Sell
200-day EMA: 128.64 Sell

The Joint Earnings Growth & JYNT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.02 per share, an increase next quarter of $0.13 per share, a decrease this year of $0.26 per share, and an increase next year of $0.55 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.96 per share, an increase next quarter of $2.81 per share, an increase this year of $4.41 per share, and an increase next year of $9.14 per share.

The Joint Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):